ScienceDex / Researcher record
Szabo, Csaba
- Inotek Pharmaceuticals Corporation (no department on record)
From the FY2002 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 5% Funded
- R01 Holder
- Diverse Portfolio
NIH Funding · FY2002
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2001 | $1,417,069 | 4 | #1,974 |
| 2002 | $3,124,316 | 7 | #502 |
| 2003 | $4,134,186 | 7 | #338 |
| 2004 | $880,465 | 3 | #5,370 |
| 2005 | $612,375 | 2 | #9,165 |
| 2017 | $232,500 | 1 | #29,999 |
| 2018 | $193,750 | 1 | #33,718 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20014 records
- FY2002 · selected7 records
- FY20037 records
- FY20043 records
- FY20052 records
- FY20171 record
- FY20181 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2018Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2002 award records by amount
NIH award records listing Szabo, Csaba as a PI. Multi-PI records show the full award amount for context.
- 2R44AR046167-02A2R44Contact PIAdenosine-3 agonists for the suppression of arthritis$730Kaward amount
- 2R44NS039216-02A1R44Contact PIPeroxynitrate neutralizing agents for stroke therapy$728.8Kaward amount
- 2R44NS037985-02A2R44Contact PIUltrapotent PARS inhibitor for CNS trauma$687Kaward amount
- 1R01HL071254-01R01Contact PIMechanisms of cardiovascular dysfunction in diabetes$405.4Kaward amount
- 2R01HL059266-04A1R01Contact PIMyicardial injury: role of poly (ADP-ribose) synthetase$287.5Kaward amount
- 5R01GM060915-04R01Contact PIPOLY (ADP RIBOSE) SYNTHETASE AND PEROXYNITRITE INDUCED C$226.7Kaward amount
- 1R43CA097559-01R43Contact PIDoxorubicin cardiotoxicity:protection by peroxynitrite$58.9Kaward amount
Award organization
Organizations that administered FY2002 awards listing Szabo, Csaba as a PI.
FY2002 award administered by Inotek Pharmaceuticals Corporation ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardInotek Pharmaceuticals Corporation
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #1974
- 2001Entered Top 25% NationallyRanked #1974
- 2001Entered Top 10% NationallyRanked #1974
- 2002$2M Cumulative Funding
- 2002Entered Top 5% NationallyRanked #502
- 2003$5M Cumulative Funding
- 2003R01 Grant Holder
- 2005$10M Cumulative Funding